Learning Objectives

1. List the symptoms that suggest the need for diagnostic testing for COPD.
2. Explain the role of spirometry to make an accurate diagnosis of COPD.
3. Discuss the pathophysiology and epidemiology of COPD.
4. Review the pharmacologic and non-pharmacologic options available in the treatment of stable COPD.
5. Summarize strategies for preventing COPD exacerbations.
6. Describe the pharmacologic and non-pharmacologic options available in the treatment of COPD exacerbations.

Target Audience

This activity is intended for Family Practice Physicians, Internal Medicine Physicians Assistants, Registered Nurses, and Nurse Practitioners.

Term of Approval

May 1, 2010 through April 30, 2012

Accreditation and Designation Statement

National Jewish Health^TM is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health^TM designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

National Jewish Health^TM is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 12724. The entire activity is approved for a total of 1.5 Nursing Contact Hours.

Participating Faculty Disclosure Information

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any or not significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., Stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

All CME Educational Activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

KEY

Adam Friedlander, MD
Staff Physician, COPD Program
National Jewish Health
Assistant Professor
Pulmonary Sciences and Critical Care Medicine
University of Colorado Denver
Has no significant financial interest to report.

Alex J. Mechaber, MD, FACP
Associate Dean for Undergraduate Medical Education
Associate Professor of Medicine
Leonard Miller School of Medicine
University of Miami
Has no significant financial interest to report.

Ronina Covar, MD
Associate Professor
Department of Pediatrics
National Jewish Health
A - Merck
I - Ross Abbott

Elaine Schwartz, MD
Associate Professor
Department of Medicine
National Jewish Health
Has no significant financial interest to report.

Cindy Lampner, MLS
Medical Writer
Has no significant financial interest to report.

Commercial Support

This program was supported by an unrestricted educational grant from AstraZeneca